Clinical trial Recruiting at 1 site Interventional Ages 20 to 40 Women only

Using Metformin to Improve Live Birth Rates in Women with Prediabetes Undergoing IVF

Official title: Effect of Metformin on Healthy Live Birth After In-vitro Fertilization in Women With Prediabetes Mellitus: a Multicenter Double-blind Placebo Controlled Randomized Trial

Run by Shandong University · NCT06064669 · Data updated 2026-11-12

This study is testing if taking metformin before IVF can help women with prediabetes have a healthier chance of getting pregnant and having a baby.

More Prediabetes trials

Quick facts

Study typeInterventional
Ages20 Years to 40 Years
SexWomen only
Enrollment988 (estimated)
SponsorShandong University
Academic / other
Locations1 site (Jinan, Shandong)
StatusRecruiting
StartedFebruary 22, 2024
Main results expectedDecember 31, 2026
Study endsDecember 31, 2027
Registry record updatedMay 29, 2024
Trial IDNCT06064669 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 20-40 with a diagnosis of prediabetes who plan to undergo a new cycle of IVF, ICSI, or PGT-A.

Probably not a fit

Patients diagnosed with diabetes or those taking medications that interfere with glucose metabolism will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the efficacy and safety of metformin pretreatment on reproductive outcomes in infertile women diagnosed with prediabetes. It aims to determine whether starting metformin before ovarian stimulation or before frozen embryo transfer can enhance the chances of achieving a healthy live birth compared to a placebo. The study involves administering metformin or placebo to participants and monitoring their reproductive outcomes during in-vitro fertilization procedures.

Why it matters

Potential benefit: If successful, this could significantly increase the likelihood of healthy live births for women with prediabetes undergoing IVF.

How similar studies have gone: Other studies have shown promising results with metformin in improving reproductive outcomes, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Women who are diagnosed with prediabetes by ADA criteria, including either IFG, IGT, or HbA1C 5.7-6.4%.
2. Women aged 20-40 years.
3. Women who plan to undergo a new cycle of IVF, ICSI, or PGT-A.

Exclusion Criteria:

1. Women who are diagnosed with diabetes according to the ADA criteria11,12, which is meeting one of the following criteria: fasting plasma glucose ≥7.0mmol/L, 2-h plasma glucose during 75-g OGTT ≥11.1mmol/L, HbA1c≥6.5%, or a random plasma glucose≥11.1mmol/L.
2. Women who are taking medicine that interfere with glucose metabolism, such as metformin, oral anti-diabetic agents (sulfonylureas, glinides, thiazolidinediones, α-glycosidase inhibitors, GLP-1 receptor agonist, etc.), weight loss drugs (i.e.orlistat, etc.), glucocorticoids, and growth hormones within 2 months before enrollment.
3. Women with un-corrected hyperthyroidism or hypothyroidism.
4. Women with congenital or acquired abnormal uterine cavity including septate uterus, unicornous uterus, uterus duplex, and intrauterine adhesions.
5. Women with a diagnosis of adenomyosis.
6. Women with untreated hydrosalpinx.
7. Women who plan to undergo PGT-SR or PGT-M.
8. Women with major medical comorbidities, such as known liver disease, known renal disease, or known significant anemia.

Where it's running

  • Shandong University
    Jinan, Shandong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.